• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞与(CD4+)CD25+调节性T细胞:免疫与耐受领域两位专家之间的相互作用

Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance.

作者信息

Chen Wanjun

机构信息

Mucosal Immunology Unit, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Heath, 30, Bethesda, MD 20892, USA.

出版信息

Front Biosci. 2006 May 1;11:1360-70. doi: 10.2741/1889.

DOI:10.2741/1889
PMID:16368522
Abstract

Dendritic cells (DCs) are professional antigen presenting cells (APCs). (CD4+)CD25+ T regulatory cells (T regs) are recognized as professional regulatory cells. DCs not only initiate T cell immunity by uptake, processing and presentation of specific antigens, but also induce immune tolerance by deletion of T cells and/or induction of regulatory T cells. (CD4+)CD25+ T regs maintain immune tolerance by suppressing the function of CD4+ and CD8+ T cells, B cells, macrophages, DCs and NK cells. It would be inconceivable that the delicate balance between immunity and tolerance could be kept impeccable without the crosstalk between DCs and (CD4+)CD25+ T regs. This review focuses on the recent development in our understanding of DCs and (CD4+)CD25+ T regs in immune tolerance, with transforming growth factor-beta (TGF-beta) serving as a potential link between these two professionals.

摘要

树突状细胞(DCs)是专职抗原呈递细胞(APCs)。(CD4 +)CD25 + T调节细胞(Tregs)被认为是专职调节细胞。DCs不仅通过摄取、加工和呈递特定抗原来启动T细胞免疫,还通过T细胞的缺失和/或调节性T细胞的诱导来诱导免疫耐受。(CD4 +)CD25 + Tregs通过抑制CD4 +和CD8 + T细胞、B细胞、巨噬细胞、DCs和NK细胞的功能来维持免疫耐受。如果没有DCs和(CD4 +)CD25 + Tregs之间的相互作用,免疫和耐受之间的微妙平衡能够保持完美无缺是不可想象的。本综述重点关注我们对DCs和(CD4 +)CD25 + Tregs在免疫耐受方面理解的最新进展,转化生长因子-β(TGF-β)作为这两种专职细胞之间的潜在联系。

相似文献

1
Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance.树突状细胞与(CD4+)CD25+调节性T细胞:免疫与耐受领域两位专家之间的相互作用
Front Biosci. 2006 May 1;11:1360-70. doi: 10.2741/1889.
2
Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.供体树突状细胞诱导的胸腺和脾脏调节性CD4+ T细胞在LF15-0195治疗诱导同种异体移植耐受中的作用。
J Immunol. 2002 May 15;168(10):5058-69. doi: 10.4049/jimmunol.168.10.5058.
3
Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells.CTLA-4的增强结合诱导抗原特异性CD4+CD25+Foxp3+和CD4+CD25-TGF-β1+适应性调节性T细胞。
J Immunol. 2007 Oct 15;179(8):5191-203. doi: 10.4049/jimmunol.179.8.5191.
4
IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.IDO 表达的成纤维细胞促进抗原特异性调节性 T 细胞的扩增。
Immunobiology. 2014 Jan;219(1):17-24. doi: 10.1016/j.imbio.2013.06.008. Epub 2013 Jun 25.
5
The characterization and role of regulatory T cells in immune reactions.调节性T细胞在免疫反应中的特征与作用。
Front Biosci. 2008 Jan 1;13:2266-74. doi: 10.2741/2840.
6
Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo.在体内存在或不存在天然CD4+CD25+调节性T细胞的情况下,超抗原诱导的调节性T细胞表现出不同的抑制功能。
J Immunol. 2003 May 15;170(10):5008-17. doi: 10.4049/jimmunol.170.10.5008.
7
Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.树突状细胞部分消除了人外周血中存在的CD4+CD25+ T细胞的调节活性。
Int Immunol. 2007 Mar;19(3):227-37. doi: 10.1093/intimm/dxl139. Epub 2007 Feb 7.
8
TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells.转化生长因子-β在T细胞激活后早期需要细胞毒性T淋巴细胞相关抗原4来诱导叉头框蛋白3并产生适应性CD4+CD25+调节性细胞。
J Immunol. 2006 Mar 15;176(6):3321-9. doi: 10.4049/jimmunol.176.6.3321.
9
[Depressive effect of cigarette smoke extracts on dendritic cells inducing differentiation of CD4+T cells into CD4+CD25+Foxp3+ Tregs].[香烟烟雾提取物对诱导树突状细胞将CD4 + T细胞分化为CD4 + CD25 + Foxp3 +调节性T细胞的抑制作用]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Jan;32(1):15-9.
10
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.由CpG寡脱氧核苷酸激活的人浆细胞样树突状细胞可诱导CD4+CD25+调节性T细胞的产生。
J Immunol. 2004 Oct 1;173(7):4433-42. doi: 10.4049/jimmunol.173.7.4433.

引用本文的文献

1
Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection.抗胸腺细胞球蛋白用于治疗T细胞介导的同种异体移植排斥反应。
World J Transplant. 2023 Dec 18;13(6):299-308. doi: 10.5500/wjt.v13.i6.299.
2
Immune System Effects on Breast Cancer.免疫系统对乳腺癌的影响。
Cell Mol Bioeng. 2021 Jun 3;14(4):279-292. doi: 10.1007/s12195-021-00679-8. eCollection 2021 Aug.
3
Immunotherapy for malignant glioma.恶性胶质瘤的免疫疗法。
Surg Neurol Int. 2015 Feb 13;6(Suppl 1):S68-77. doi: 10.4103/2152-7806.151341. eCollection 2015.
4
Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis.干酪乳杆菌 NCDO 2118 在化学诱导结肠炎缓解期的抗炎作用。
Gut Pathog. 2014 Jul 29;6:33. doi: 10.1186/1757-4749-6-33. eCollection 2014.
5
Is there a role for probiotics in the prevention or treatment of food allergy?益生菌在预防或治疗食物过敏方面是否有作用?
Curr Allergy Asthma Rep. 2013 Dec;13(6):622-30. doi: 10.1007/s11882-013-0381-9.
6
Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?腺苷作为癌症发病机制中的内源性免疫调节剂:路在何方?
Purinergic Signal. 2013 Jun;9(2):145-65. doi: 10.1007/s11302-012-9349-9. Epub 2012 Dec 28.
7
Effective modulation of CD4(+)CD25 (+high) regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2.恶性肿瘤患者经干扰素-α和白细胞介素-2联合治疗后,其 CD4(+)CD25 (+high) 调节性 T 和 NK 细胞得到有效调节。
Cancer Immunol Immunother. 2012 Dec;61(12):2357-66. doi: 10.1007/s00262-012-1297-2. Epub 2012 Jun 22.
8
Biomarkers of transplantation tolerance: more hopeful than helpful?移植耐受的生物标志物:比有希望更有用?
Front Immunol. 2011 Apr 6;2:9. doi: 10.3389/fimmu.2011.00009. eCollection 2011.
9
Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?1型糖尿病免疫疗法的现状:渐进式进展、巨大飞跃还是原地踏步?
Clin Dev Immunol. 2011;2011:432016. doi: 10.1155/2011/432016. Epub 2011 Jul 18.
10
Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.体外树突状细胞生成过程中磷酸肌醇 3-激酶的活性决定了其抑制或刺激能力。
Immunol Res. 2011 Aug;50(2-3):130-52. doi: 10.1007/s12026-011-8206-1.